These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 27128613

  • 1. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T, Hubbell J, Kantesaria B, Hanson ME, Cutler DL.
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T, Hubbell J, Xuan F, Cutler DL, Meehan AG, Kantesaria B, Wittmer BA.
    Int J Chron Obstruct Pulmon Dis; 2013 May; 8():107-16. PubMed ID: 23525511
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A, Riddell K, Joshi S, Chan R, Mehta R.
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R, Moore A, Riddell K, Joshi S, Chan R.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [Abstract] [Full Text] [Related]

  • 8. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD.
    Kerwin EM, Siler TM, Arora S, Darken P, Rose E, Reisner C.
    Int J Chron Obstruct Pulmon Dis; 2018 Dec; 13():1483-1494. PubMed ID: 29773947
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
    Ferguson GT, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, Martin UJ.
    Int J Chron Obstruct Pulmon Dis; 2018 Dec; 13():945-953. PubMed ID: 29606861
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
    Nolte H, Pavord I, Backer V, Spector S, Shekar T, Gates D, Nair P, Hargreave F.
    Respir Med; 2013 May; 107(5):656-64. PubMed ID: 23490226
    [Abstract] [Full Text] [Related]

  • 11. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB, Kosoglou T, Thonoor CM, Flannery BE, Herron JM.
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M, Song S, Steinfeld J.
    Allergy Asthma Proc; 2015 Dec; 36(5):365-71. PubMed ID: 26314817
    [Abstract] [Full Text] [Related]

  • 13. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [Abstract] [Full Text] [Related]

  • 14. Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers.
    Affrime MB, Cuss F, Padhi D, Wirth M, Pai S, Clement RP, Lim J, Kantesaria B, Alton K, Cayen MN.
    J Clin Pharmacol; 2000 Nov; 40(11):1227-36. PubMed ID: 11075308
    [Abstract] [Full Text] [Related]

  • 15. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
    Maspero JF, Nolte H, Chérrez-Ojeda I, P04139 Study Group.
    J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
    [Abstract] [Full Text] [Related]

  • 16. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
    Dorinsky P, DePetrillo P, DeAngelis K, Trivedi R, Darken P, Gillen M.
    Clin Ther; 2020 Apr; 42(4):634-648. PubMed ID: 32253054
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
    Dunn LJ, Kerwin EM, DeAngelis K, Darken P, Gillen M, Dorinsky P.
    Pulm Pharmacol Ther; 2020 Feb; 60():101873. PubMed ID: 31841699
    [Abstract] [Full Text] [Related]

  • 18. A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
    Reisner C, Fabbri LM, Kerwin EM, Fogarty C, Spangenthal S, Rabe KF, Ferguson GT, Martinez FJ, Donohue JF, Darken P, St Rose E, Orevillo C, Strom S, Fischer T, Golden M, Dwivedi S.
    Respir Res; 2017 Jan 06; 18(1):8. PubMed ID: 28061907
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M, Leflein J, Corren J, Staudinger H.
    BMC Pediatr; 2009 Jul 13; 9():43. PubMed ID: 19594937
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
    Darken P, DePetrillo P, Reisner C, St Rose E, Dorinsky P.
    Pulm Pharmacol Ther; 2018 Jun 13; 50():11-18. PubMed ID: 29544728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.